Brain tumor-targeted drug delivery strategies

Area of Science:

• Neuro-oncology
• Nanomedicine
• Pharmacology

Background:

• Brain tumors present significant therapeutic challenges due to rapid growth and poor prognosis, even with aggressive treatments.
• Current therapies often lack specificity, leading to systemic toxicity and limited efficacy.
• Targeted drug delivery systems (TDDS) are emerging as a promising strategy to improve brain tumor treatment outcomes.

Purpose of the Study:

• To review the unique physiological characteristics of brain tumors relevant to targeted drug delivery.
• To explore existing and novel targeted delivery strategies for brain tumors.
• To propose a systematic approach for overcoming challenges in brain tumor drug delivery.

Main Methods:

• Comprehensive literature review of brain tumor physiology and targeted drug delivery systems.
• Analysis of distinctive brain tumor characteristics, including the blood-brain barrier, tumor microenvironment, and tumor stem cells.
• Evaluation of various targeting strategies based on physiological and microenvironmental cues.

Main Results:

• Brain tumors possess unique features like altered vasculature and microenvironment that can be exploited for targeted delivery.
• Understanding these characteristics is crucial for designing effective TDDS.
• Several targeting strategies show potential for enhanced drug accumulation and reduced toxicity.

Conclusions:

• Targeted drug delivery holds significant promise for improving the efficacy and safety of brain tumor treatments.
• Exploiting specific brain tumor characteristics is key to successful targeted therapy.
• A systematic approach is needed to overcome existing challenges and advance brain tumor drug delivery.